Cargando…
Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases
Squalene–hopene cyclases (SHCs) have great potential for the industrial synthesis of enantiopure cyclic terpenoids. A limitation of SHC catalysis has been the enzymes’ strict (S)‐enantioselectivity at the stereocenter formed after the first cyclization step. To gain enantio‐complementary access to v...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290348/ https://www.ncbi.nlm.nih.gov/pubmed/34346556 http://dx.doi.org/10.1002/anie.202108037 |
_version_ | 1784748878785937408 |
---|---|
author | Eichenberger, Michael Hüppi, Sean Patsch, David Aeberli, Natalie Berweger, Raphael Dossenbach, Sandro Eichhorn, Eric Flachsmann, Felix Hortencio, Lucas Voirol, Francis Vollenweider, Sabine Bornscheuer, Uwe T. Buller, Rebecca |
author_facet | Eichenberger, Michael Hüppi, Sean Patsch, David Aeberli, Natalie Berweger, Raphael Dossenbach, Sandro Eichhorn, Eric Flachsmann, Felix Hortencio, Lucas Voirol, Francis Vollenweider, Sabine Bornscheuer, Uwe T. Buller, Rebecca |
author_sort | Eichenberger, Michael |
collection | PubMed |
description | Squalene–hopene cyclases (SHCs) have great potential for the industrial synthesis of enantiopure cyclic terpenoids. A limitation of SHC catalysis has been the enzymes’ strict (S)‐enantioselectivity at the stereocenter formed after the first cyclization step. To gain enantio‐complementary access to valuable monocyclic terpenoids, an SHC‐wild‐type library including 18 novel homologs was set up. A previously not described SHC (AciSHC) was found to synthesize small amounts of monocyclic (R)‐γ‐dihydroionone from (E/Z)‐geranylacetone. Using enzyme and process optimization, the conversion to the desired product was increased to 79 %. Notably, analyzed AciSHC variants could finely differentiate between the geometric geranylacetone isomers: While the (Z)‐isomer yielded the desired monocyclic (R)‐γ‐dihydroionone (>99 % ee), the (E)‐isomer was converted to the (S,S)‐bicyclic ether (>95 % ee). Applying the knowledge gained from the observed stereodivergent and enantioselective transformations to an additional SHC‐substrate pair, access to the complementary (S)‐γ‐dihydroionone (>99.9 % ee) could be obtained. |
format | Online Article Text |
id | pubmed-9290348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92903482022-07-20 Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases Eichenberger, Michael Hüppi, Sean Patsch, David Aeberli, Natalie Berweger, Raphael Dossenbach, Sandro Eichhorn, Eric Flachsmann, Felix Hortencio, Lucas Voirol, Francis Vollenweider, Sabine Bornscheuer, Uwe T. Buller, Rebecca Angew Chem Int Ed Engl Research Articles Squalene–hopene cyclases (SHCs) have great potential for the industrial synthesis of enantiopure cyclic terpenoids. A limitation of SHC catalysis has been the enzymes’ strict (S)‐enantioselectivity at the stereocenter formed after the first cyclization step. To gain enantio‐complementary access to valuable monocyclic terpenoids, an SHC‐wild‐type library including 18 novel homologs was set up. A previously not described SHC (AciSHC) was found to synthesize small amounts of monocyclic (R)‐γ‐dihydroionone from (E/Z)‐geranylacetone. Using enzyme and process optimization, the conversion to the desired product was increased to 79 %. Notably, analyzed AciSHC variants could finely differentiate between the geometric geranylacetone isomers: While the (Z)‐isomer yielded the desired monocyclic (R)‐γ‐dihydroionone (>99 % ee), the (E)‐isomer was converted to the (S,S)‐bicyclic ether (>95 % ee). Applying the knowledge gained from the observed stereodivergent and enantioselective transformations to an additional SHC‐substrate pair, access to the complementary (S)‐γ‐dihydroionone (>99.9 % ee) could be obtained. John Wiley and Sons Inc. 2021-09-17 2021-12-06 /pmc/articles/PMC9290348/ /pubmed/34346556 http://dx.doi.org/10.1002/anie.202108037 Text en © 2021 The Authors. Published by Wiley-VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Eichenberger, Michael Hüppi, Sean Patsch, David Aeberli, Natalie Berweger, Raphael Dossenbach, Sandro Eichhorn, Eric Flachsmann, Felix Hortencio, Lucas Voirol, Francis Vollenweider, Sabine Bornscheuer, Uwe T. Buller, Rebecca Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases |
title | Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases |
title_full | Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases |
title_fullStr | Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases |
title_full_unstemmed | Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases |
title_short | Asymmetric Cation‐Olefin Monocyclization by Engineered Squalene–Hopene Cyclases |
title_sort | asymmetric cation‐olefin monocyclization by engineered squalene–hopene cyclases |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290348/ https://www.ncbi.nlm.nih.gov/pubmed/34346556 http://dx.doi.org/10.1002/anie.202108037 |
work_keys_str_mv | AT eichenbergermichael asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT huppisean asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT patschdavid asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT aeberlinatalie asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT berwegerraphael asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT dossenbachsandro asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT eichhorneric asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT flachsmannfelix asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT hortenciolucas asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT voirolfrancis asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT vollenweidersabine asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT bornscheueruwet asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases AT bullerrebecca asymmetriccationolefinmonocyclizationbyengineeredsqualenehopenecyclases |